Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s Product Parachute? Firm Could See Rally Around New Approvals

30 Jan 2006

• By Jessica Merrill and Mary Jo Laffler

Related Content

Bristol Swallows Cost-Cutting Pill To Dull Pargluva Pain; Sales Force May Shrink

19 Dec 2005

Merck Sales Restructuring Sacrifices Physician Detailing To Payer Marketing

19 Dec 2005

Pargluva Panic: Need For Additional Trial Prompts Merck To Drop Partnership

31 Oct 2005

Pfizer Will Review Cholesterol Drug Category To Gauge Longevity Of Slowdown

24 Oct 2005

Tough Sell? Pfizer CEO Outlines Lipitor Game Plan For Generic Zocor

09 Jan 2006

Welcome To Medicare: Pfizer Sees Part D As Key To Rebirth

09 Jan 2006

Pfizer Cutting Cost Of R&D Under Efficiency Program; Output To Double

25 Jul 2005

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.